• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

    InspireMD's CEO Steps Down

    Celmatix Sues Research Partner 23andMe for $100M

    FDA Cleared New Cochlear Osia 2 System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NN Life Sciences/Paragon Medical

    FUTEK Advanced Sensor Technology Inc.

    Glenbrook Technologies Inc.

    Pulse Systems

    Accumold
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    K-Tube Technologies

    GS Plastic Optics

    Carclo Technical Plastics

    NN Life Sciences/Paragon Medical

    RJG Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    So We’re All on the Same Page: You Need a Test Plan

    So We’re All on the Same Page: You Need a Test Plan
    Related CONTENT
    • Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?
    • Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    • Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel
    • Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval
    • Pro Tips for Prototypes: The Smart Way to Manage Device Iterations
    Dawn A. Lissy, Empirical09.01.17
    I’m a huge fan of lists. Covering every base with an organized way to track everything from my companies’ financial progress to whether the Doritos made it into the car for the drive home from school keeps me functioning. I note things on my computer, tablet, smartphone, spiral paper planner, and a series of Post-it notes that wing up around my office like neon butterflies.

    It would never occur to me to not have a test plan. But I frequently find myself explaining the benefits of a plan to clients and dispelling a series of misunderstandings about how a test plan can make the development cycle easier and less expensive. I’ve even had clients who have never heard of such a thing and wonder why anyone would ever craft one.
    I have special list just for them.

    “Less expensive” typically catches everyone’s attention when explaining the benefits of devising a test plan. It varies from client to client, but some have saved as much as 30 percent of overall testing time and financial costs, depending on the type and scope of project. A testing plan solid enough to be the foundation of a successful project yet fluid enough to allow for course corrections eases the path to market—particularly for Class III devices.

    “Easier” is a subjective measurement, however; there’s not necessarily a bottom line or hard number attached to it. But based on what I’ve noticed over the course of my career, it’s better to form a test plan at the beginning of the development cycle. If you wait until mid-cycle, a challenge that could’ve been foreseen might sideline the project and measures must then be put in place to deal with it.

    The Why
    Clients have argued a test plan could limit their options and they don’t want to feel pigeon-holed or wedded to a single path. But after considering the options and plotting the course, identify where and when that plan may need reassessment. The plan will not be carved in stone. Hopefully it won’t manifest in fluorescent paper slips all over the office, but rather a happy medium that allows forward momentum and won’t trap you in a corner.

    Plan Before You Plan
    A failure modes and effects analysis (FMEA) is a risk analysis and starting point. This is a must for Class III devices as well as Class II devices containing a feature with the potential to cause harm, such as an intervertebral body fusion device (IBFD) with a new locking mechanism for expansion purposes. The FMEA will determine any additional testing to consider in order to prove the overall safety and efficacy of the device—benchtop testing, animal testing, or other evaluations needed in the overall test plan. For Class III devices, you’ll also want to consider feasibility testing. Again, this may apply for Class IIs with breakthrough technology applications.

    Now the actual plan is ready to be developed. Feel free to dust off my article “Driving a Successful Medical Device Product Development Cycle” in the July/August 2015 edition of MPO for more details on putting that plan together, but it should include minimum required tests from relevant regulatory agencies, in addition to feasibility or other evaluations identified during the risk analysis.

    More Than Guidance Documents
    Some clients have argued that they don’t need a plan because there are regulatory documents that spell out required tests. While established guidelines and regulatory direction are great fodder for a plan, they’re not an actual process guide for a device. The U.S. Food and Drug Administration’s guidance documents serve as the foundation and minimum requirements, but they’re not a device-specific path to market.

    It’s easy to over- or under-test if those documents aren’t read correctly. Some devices such as vertebral body replacements or cervical or lumbar IBFDs can be tested to up to six different methods per the American Society for Testing and Materials (ASTM) standards. But not every device needs all six tests depending on its indication and location. Only two of six tests have to be performed on a monolithic lumbar device. Knowing the regulatory requirements for the specific kind of device helps to put the best plan in place to use time, money, and testing wisely. With Class III devices, there may not be a standard to test a device to, thereby requiring a test plan to propose to the regulatory agency.

    I’ve actually had face-palm moments when a client informs me they performed all six tests when they only needed four. They covered their bases mid-process because they didn’t have a plan, which cost them time and money they didn’t need to spend.

    Let’s also consider who you’re working with. The regulatory community is full of planners. Anyone who reports to a governmental agency—regardless of what country it’s in—has a series of boxes to check. It will be easier on everyone if a document to share with reviewers at any point in the cycle is available.

    Putting It in Writing
    When developing a test plan, you’re making a map—creating a document that will enable the entire team to literally be on the same page. This is where you’re doing homework and will see potential liabilities as well as possible shortcuts. Once this critical baseline is obtained, a realistic timeline and the bookends of possibilities can be developed. Best-case to worse-case scenarios and where/when those issues can pop up will be known.

    With this outline of major deadlines and turning points, you’ll be able to allocate resources and refine schedules to smooth the journey.

    Everyone will have the deadlines, everyone will get the same information, and the whole team will work off the same document. Given the number and variety of people that must work together to get a medical device to market—regulatory, manufacturing, production development, surgeons, etc.—this is essential. If everyone understands what the steps are and that those steps can’t be skipped, precious time will not be wasted. It’s ultimately about setting and managing stakeholder expectations.

    Bringing the Future to the Present
    Alan Lakein, author of “How to Get Control of Your Time and Your Life,” sums it up nicely: “Planning is bringing the future into the present so you can do something about it now.”
    Consider the future of the device, the team, and your goals. Then bring all of that into the present with a test plan that will move the endeavor forward to meet those goals. 


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting, LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio.
    Related Searches
    • 2015
    • patent
    • quality
    • fluorescent
    Related Knowledge Center
    • Testing
    Suggested For You
    Pro Tips for Prototypes: The Smart Way to Manage Device Iterations Pro Tips for Prototypes: The Smart Way to Manage Device Iterations
    Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval
    Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel
    Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House? Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?

    Related Columns

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Testing
      Why Big Companies With Internal Labs Should Outsource Testing

      Why Big Companies With Internal Labs Should Outsource Testing

      Most of us know when we’ve hit that line signaling we’ve left our cutting edge and officially spread ourselves too thin. Pushing to do and be more is often a half-step from maxing out and dropping all those balls we’re juggling.…
      Dawn A. Lissy, President & Founder, Empirical 03.07.19


    • Packaging & Sterilization | Testing
      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Five years ago, I shuddered to read the headlines about “dirty” endoscopes being used in colonoscopies and the speculation that followed. Are colonoscopies really safe? Is this what’s creating new superbugs? Why weren’t hospit…
      Dawn A. Lissy, President & Founder, Empirical 07.26.18

    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      In a year of political and social discord, international conflict, and natural disasters, the big news in the medical device industry really didn’t make headlines—even within our sector. But as 2017 comes to a close, I consider fee hikes,…
      Dawn A. Lissy, President & Founder, Empirical 11.07.17

    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      Most discussions on packaging validations for medical devices begin and end with ISO 11607: Packaging for Terminally Sterilized Medical Devices, and are laden with interpretations of how the two parts of this standard apply best to the unique aspects…
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17


    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      There’s something about hitting the prototype stage of the development cycle that makes everything finally seem real. This is the point at which there is finally an object to hold in your hands—a physical representation of the vision, inv…
      Dawn A. Lissy, Empirical 07.26.17

    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      It was the U.S. Food and Drug Administration’s (FDA) worst nightmare come true. On May 12, the WannaCry ransomware cryptoworm slithered its way into computers worldwide, infecting as many as 200,000 Microsoft Windows systems in 150 countries…
      Michael Barbella, Managing Editor 06.06.17

    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      Humans come in all shapes and sizes, ages, and abilities. Sometimes they aren’t logical. Engineers come with logical, rational minds, but sometimes don’t consider emotional behavior. Factoring humans into device design is not always a pre…
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17


    • Testing
      Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals

      Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals

      It was a lot to take in running on about five hours of sleep following an international flight complete with a lost luggage cliché. Representatives from multiple agencies—governmental, regulatory, medical device companies, hospital purch…
      Dawn A. Lissy, President & Founder, Empirical 04.03.17

    • Testing
      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      It has become more prevalent and acceptable to use the results of chemistry testing to assess the overall biocompatibility of medical devices. For many devices with prolonged or permanent patient contact, chemistry followed by toxicological assessmen…
      Matthew R Jorgensen, Ph.D., and Thor Rollins, BS, Nelson Laboratories; Allison Komiyama, Ph.D., RAC, AcKnowledge RS 04.03.17

    • Testing
      Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?

      Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?

      When people ask me what I do, I often reply, “I break things for a living.” Yes, I say it with tongue firmly in cheek. That’s a gross oversimplification of a business I’ve been in for almost 20 years: mechanical testing for…
      Dawn A. Lissy, President & Founder, Empirical 03.07.17

    • Cardiovascular | Diagnostics | Neurological | Patient Monitoring | R&D & Design | Surgical | Testing
      First in Man

      First in Man

      There are two main paths for clinical studies in the United States for medical devices. The first is the most common, called a traditional study. This approach follows a U.S. Food and Drug Administration (FDA) design process including agency testing,…
      Steve Maylish, Chief Commercial Officer, Fusion Biotec 03.07.17

    • Contract Manufacturing | Testing
      Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market

      Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market

      When Cartiva Inc. successfully sped through their Class III device premarket panel in less than half the average time—71 days instead of 159—that caught my attention. For more than 18 years, the Empirical family of companies has partnered…
      Dawn A. Lissy, President & Founder, Empirical 01.30.17

    • Contract Manufacturing | R&D & Design | Testing
      Don’t Blame ISO for Inefficient Operations

      Don’t Blame ISO for Inefficient Operations

      I’ve heard executives say their small to medium-sized for-profit manufacturing or service company is not operating efficiently because of ISO bureaucracy—specifically, the ISO 9001 Quality Management System or its related standards (ISO 1…
      James A. Dunning, Owner, QPC Services, LLC 01.30.17


    Breaking News
    • 15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    • Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    • InspireMD's CEO Steps Down
    • Celmatix Sues Research Partner 23andMe for $100M
    • FDA Cleared New Cochlear Osia 2 System
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    InspireMD's CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    TriMed Closes Out FDA Warning Letter
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.